Clinical TrialRSS

Show map

A4

Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Study. Tests the hypothesis that solanezumab, administered as an intravenous infusion at a dose of 400 mg every 4 weeks for 3 years, will slow cognitive decline as compared with placebo in s ...

Telephone855-LOU-RUVO or (855-562-7886)
E-mail
Therapuetic AreaCognitively Normal
Study TypeClinical Trial

(age 50-90)

Telephone855-LOU-RUVO or (855-568-7886)
E-mail
Therapuetic AreaNeurodegeneration
Study TypeClinical Trial

(age 60-85)

Telephone855-LOU-RUVO or (855-568-7886)
E-mail
Therapuetic AreaAsymptomatic Alzheimer’s disease
Study TypeClinical Trial

(age 50-85)

Telephone855-LOU-RUVO or (855-568-7886)
E-mail
Therapuetic AreaMild Cognitive Impairment
Study TypeClinical Trial

Registry for APOE Genotype (age 55-75)

Telephone855-LOU-RUVO or (855-568-7886)
E-mail
Therapuetic AreaNormal asymptomatic
Study TypeClinical Trial

(age 60-75)

Telephone855-LOU-RUVO or (855-568-7886)
E-mail
Therapuetic AreaAPOE HZ
Study TypeClinical Trial

(age 65 and up) Imaging dementia for amyloid scanning

Telephone855-LOU-RUVO or (855-568-7886)
E-mail
Therapuetic AreaMedicare
Study TypeClinical Trial

(age 50-85)

Telephone855-LOU-RUVO or (855-568-7886)
E-mail
Therapuetic AreaMild Cognitive Impairment due to Alzheimer’s disease, E...
Study TypeClinical Trial

(age 50-90)

Telephone855-LOU-RUVO or (855-568-7886)
E-mail
Therapuetic AreaMild to Moderate Alzheimer’s disease
Study TypeClinical Trial

Your Resource Centers

Serving Nevadans since 2005!

Northern Nevada

Rural Nevada

Southern Nevada

 

NWD Coordinator

Jamie Ahumada
3416 Goni Road
Carson City, NV 89706

Email: